Von dem Buch New Products and New Areas of Bioprocess Engineering haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Colaborador: Marin Berovic, Colaborador: B. Contreras, Colaborador: M. Dueser, Colaborador: N. Krieger, Colaborador: M. Menge, Colaborador: D.A. Mitchel, Colaborador: J. Mukherjee, Colaborador: K.S.M.S Raghavarao, Colaborador: E. Sablon, Redactor: Thomas : New Products and New Areas of Bioprocess Engineering (ISBN: 9783540673620) 2000, in Englisch, Broschiert.Nur diese Ausgabe anzeigen…
100%: Mitarbeiter: M. Berovic, Mitarbeiter: B. Contreras, Mitarbeiter: M. Dueser, Mitarbeiter: N. Krieger, Mitarbeiter: M. Menge, Mitarbeiter: D.A. Mitchel, Mitarbeiter: J. Mukherjee, Mitarbeiter: K.S.M.S. Raghavarao, Mitarbeiter: E. Sablon, Mitarbeiter: K. Sch: New Products and New Areas of Bioprocess Engineering: vol 68 (Advances in Biochemical Engineering Biotechnology) (ISBN: 9783540455646) 2000, Erstausgabe, in Englisch, Band: 68, auch als eBook.Nur diese Ausgabe anzeigen…
New Products and New Areas of Bioprocess Engineering
14 Angebote vergleichen
| Preise | 2013 | 2014 | 2015 | 2016 | 2019 |
|---|---|---|---|---|---|
| Schnitt | € 133,54 | € 254,66 | € 245,99 | € 128,54 | € 343,30 |
| Nachfrage |
1
Symbolbild
New Products and New Areas of Bioprocess Engineering (Advances in Biochemical Engineering/Biotechnology) (vol 68)
DE HC USISBN: 9783540673620 bzw. 3540673628, in Deutsch, Springer, gebundenes Buch, gebraucht.
Von Händler/Antiquariat, Crashing Rocks Books [55397785], Punta Gorda, FL, U.S.A.
3540673628 USED BOOK in good condition| No supplements| Normal wear to cover, edges, spine, corners, and pages | Writing / highlighting | Inventory stickers | Satisfaction guaranteed!
3540673628 USED BOOK in good condition| No supplements| Normal wear to cover, edges, spine, corners, and pages | Writing / highlighting | Inventory stickers | Satisfaction guaranteed!
2
Symbolbild
New Products and New Areas of Bioprocess Engineering (Advances in Biochemical Engineering/Biotechnology) (vol 68)
DE USISBN: 9783540673620 bzw. 3540673628, in Deutsch, Springer, gebraucht.
Von Händler/Antiquariat, Phatpocket Limited [8420744], Waltham Abbey, HERTS, United Kingdom.
Used - Very Good. Ex-library, but has been well cared for.
Used - Very Good. Ex-library, but has been well cared for.
3
New Products and New Areas of Bioprocess Engineering
EN NW EB DLISBN: 9783540455646 bzw. 3540455647, in Englisch, Springer, Berlin/Heidelberg, Deutschland, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
Today, ergot alkaloids have found widespread clinical use and more than 50 formulations contain natural or semisynthetic ergot alkaloids. They are used in the treatment of uterine atonia, postpartum bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, hypertension, hyp- prolactinemia, acromegaly, and Parkinsonism. Recently, new therapeutic - plications have emerged, e.g., against schizophrenia and for therapeutic usage based on newly discovered antibacterial and cytostatic effects,immunomodu- tory and hypolipemic activity.The broad physiological effects of ergot alkaloids are based mostly on their interactions with neurotransmitter receptors on the cells. The presence of “hidden structures’’ resembling some important neu- humoral mediators (e.g., noradrenaline, serotonin, dopamine) in the molecules of ergot alkaloids could explain their interactions with these receptors [1]. Ergot alkaloids are produced by the filamentous fungi of the genus, Claviceps (e.g., Claviceps purpurea – Ergot, Mutterkorn). On the industrial scale these alkaloids were produced mostly by parasitic cultivation (field production of the ergot) till the end of the 1970s. Today this uneconomic method has been - placed by submerged fermentation. Even after a century of research on ergot alkaloids the search still continues for new, more potent and more selective ergot alkaloid derivatives.
Today, ergot alkaloids have found widespread clinical use and more than 50 formulations contain natural or semisynthetic ergot alkaloids. They are used in the treatment of uterine atonia, postpartum bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, hypertension, hyp- prolactinemia, acromegaly, and Parkinsonism. Recently, new therapeutic - plications have emerged, e.g., against schizophrenia and for therapeutic usage based on newly discovered antibacterial and cytostatic effects,immunomodu- tory and hypolipemic activity.The broad physiological effects of ergot alkaloids are based mostly on their interactions with neurotransmitter receptors on the cells. The presence of “hidden structures’’ resembling some important neu- humoral mediators (e.g., noradrenaline, serotonin, dopamine) in the molecules of ergot alkaloids could explain their interactions with these receptors [1]. Ergot alkaloids are produced by the filamentous fungi of the genus, Claviceps (e.g., Claviceps purpurea – Ergot, Mutterkorn). On the industrial scale these alkaloids were produced mostly by parasitic cultivation (field production of the ergot) till the end of the 1970s. Today this uneconomic method has been - placed by submerged fermentation. Even after a century of research on ergot alkaloids the search still continues for new, more potent and more selective ergot alkaloid derivatives.
4
New Products and New Areas of Bioprocess Engineering
EN NW EB DLISBN: 9783540455646 bzw. 3540455647, in Englisch, Springer, Berlin/Heidelberg, Deutschland, neu, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
Today, ergot alkaloids have found widespread clinical use and more than 50 formulations contain natural or semisynthetic ergot alkaloids. They are used in the treatment of uterine atonia, postpartum bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, hypertension, hyp- prolactinemia, acromegaly, and Parkinsonism. Recently, new therapeutic - plications have emerged, e.g., against schizophrenia and for therapeutic usage based on newly discovered antibacterial and cytostatic effects,immunomodu- tory and hypolipemic activity.The broad physiological effects of ergot alkaloids are based mostly on their interactions with neurotransmitter receptors on the cells. The presence of “hidden structures'' resembling some important neu- humoral mediators (e.g., noradrenaline, serotonin, dopamine) in the molecules of ergot alkaloids could explain their interactions with these receptors [1]. Ergot alkaloids are produced by the filamentous fungi of the genus, Claviceps (e.g., Claviceps purpurea – Ergot, Mutterkorn). On the industrial scale these alkaloids were produced mostly by parasitic cultivation (field production of the ergot) till the end of the 1970s. Today this uneconomic method has been - placed by submerged fermentation. Even after a century of research on ergot alkaloids the search still continues for new, more potent and more selective ergot alkaloid derivatives.
Today, ergot alkaloids have found widespread clinical use and more than 50 formulations contain natural or semisynthetic ergot alkaloids. They are used in the treatment of uterine atonia, postpartum bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, hypertension, hyp- prolactinemia, acromegaly, and Parkinsonism. Recently, new therapeutic - plications have emerged, e.g., against schizophrenia and for therapeutic usage based on newly discovered antibacterial and cytostatic effects,immunomodu- tory and hypolipemic activity.The broad physiological effects of ergot alkaloids are based mostly on their interactions with neurotransmitter receptors on the cells. The presence of “hidden structures'' resembling some important neu- humoral mediators (e.g., noradrenaline, serotonin, dopamine) in the molecules of ergot alkaloids could explain their interactions with these receptors [1]. Ergot alkaloids are produced by the filamentous fungi of the genus, Claviceps (e.g., Claviceps purpurea – Ergot, Mutterkorn). On the industrial scale these alkaloids were produced mostly by parasitic cultivation (field production of the ergot) till the end of the 1970s. Today this uneconomic method has been - placed by submerged fermentation. Even after a century of research on ergot alkaloids the search still continues for new, more potent and more selective ergot alkaloid derivatives.
5
New Products and New Areas of Bioprocess Engineering | Springer | 2000
~EN NWISBN: 9783540673620 bzw. 3540673628, vermutlich in Englisch, Springer, neu.
Today, ergot alkaloids have found widespread clinical use and more than 50 formulations contain natural or semisynthetic ergot alkaloids. They are used in the treatment of uterine atonia, postpartum bleeding, migraine, orthostatic circulatory disturbances, senile cerebral insufficiency, hypertension, hyp- prolactinemia, acromegaly, and Parkinsonism. Recently, new therapeutic - plications have emerged, e.g., against schizophrenia and for therapeutic usage based on newly discovered antibacterial and cytostatic effects,immunomodu- tory and hypolipemic activity.The broad physiological effects of ergot alkaloids are based mostly on their interactions with neurotransmitter receptors on the cells. The presence of hidden structures resembling some important neu- humoral mediators (e.g., noradrenaline, serotonin, dopamine) in the molecules of ergot alkaloids could explain their interactions with these receptors [1]. Ergot alkaloids are produced by the filamentous fungi of the genus, Claviceps (e.g., Claviceps purpurea Ergot, Mutterkorn). On the industrial scale these alkaloids were produced mostly by parasitic cultivation (field production of the ergot) till the end of the 1970s. Today this uneconomic method has been - placed by submerged fermentation. Even after a century of research on ergot alkaloids the search still continues for new, more potent and more selective ergot alkaloid derivatives.
7
New Products and New Areas of Bioprocess Engineering
EN USISBN: 9783540673620 bzw. 3540673628, in Englisch, Springer Verlag, Springer Verlag, Springer Verlag, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, in-stock.
New Products and New Areas of Bioprocess Engineering.
New Products and New Areas of Bioprocess Engineering.
9
New Products and New Areas of Bioprocess Engineering (2000)
~EN HC NWISBN: 9783540673620 bzw. 3540673628, vermutlich in Englisch, Springer, Berlin/Heidelberg, Deutschland, gebundenes Buch, neu.
Lieferung aus: Deutschland, Next Day, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
10
New Products and New Areas of Bioprocess Engineering
~EN NW EB DLISBN: 9783540455646 bzw. 3540455647, vermutlich in Englisch, Springer Berlin Heidelberg, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
New Products and New Areas of Bioprocess Engineering: Englisch, Ebook.
New Products and New Areas of Bioprocess Engineering: Englisch, Ebook.
Lade…